Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
What's Inside the Box
The captured RGB image was transformed to the L * , a * , b * color space (CIE 1976, CIELAB)
Target outcomes at 6 months: BFM reduced by 35 kg, SMM stable or improved, VFL reduced by 2 levels, BMR within 100 kcal of baseline, Phase Angle stable or improved
For obesity management, NICE technology appraisals specify strict eligibility criteria for liraglutide (Saxenda) and semaglutide (Wegovy)
Limited safety data on combinations in existing literature further emphasizes the need for cautious protocol design
Key Mechanism of Action GIP receptor activation: Enhances insulin secretion and sensitivity
)
US$ 25.20
US$ 25.03
US$ 23.87
US$ 22.34
